Condition
Pericapsular Nerve
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Unknown2
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06904703Not ApplicableRecruitingPrimary
Pericapsular Nerve Group and Lumbar Erector Spinae Plane Blocks for Geriatrics Undergoing Total Hip Arthroplasty
NCT05654519Not ApplicableCompleted
Comparison of Pericapsular Nerve Group Block and Quadratus Lumborum Block
NCT05600244Not ApplicableUnknown
PENG vs. QLB vs. Lumbar ESPB in Total Hip Surgery
NCT05460442Not ApplicableUnknown
Pericapsular Nerve Group Block Versus Fascia Iliaca Block for Pediatric Hip Surgery
Showing all 4 trials